Pacific Biosciences
Manufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1305 Obrien Dr, Menlo Park, California, ...Phone Number
(650) 521-8000Website
www.pacb.comRevenue
$159.3 MillionStock Symbol
PACBIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Pacific Biosciences
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. The company's innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology.Explore more
Pacific Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pacific Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Pacific Biosciences recently announced quarterly report
Click to see if Pacific Biosciences had a recent Job posting/layoffs
Check if Pacific Biosciences has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Pacific Biosciences has new funding data
Check out if Pacific Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Pacific Biosciences
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Pacific Biosciences launches new products
Pacific Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Pacific Biosciences
Find 3 more new buyers
Compare Similar Companies to Pacific Biosciences
Compare insights from companies similar to Pacific Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pacific Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pacific Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pacific Biosciences.
Pacific Biosciences financials insights
Gather financial insights about Pacific Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series D
$50M
2008
Series E
$100M
2009
Other Financing Round
$68M
2010
Series F
$109M
Stock Offering
$200M
2013
Debt
$20.5M
2018
Stock Offering
$30M
Stock Offering
$60M
2021
Series A
$900M
Pacific Biosciences Tech Stack
A closer look at the technologies used by Pacific Biosciences
See more technologies
Most Recent Scoops
Earnings
Pacific Biosciences has reported that clinical consumables grew 67% year-over-year in Q2, representing approximately 15% of total consumables, with EMEA growing over 50% year-over-year, driven by favorable reimbursement conditions for whole-genome sequencing and the Revio platform's suitability for localized hospital settings in single-payer markets.
Medical Research, Clinical Operations, Healthcare Operations
Earnings
anticipates $15 to $20 million in decreased expenses related to its recent reduction in force, with an additional $30 to $40 million in decreased spend anticipated in 2027, as major expenditures related to the company's next high-throughput instrument wind down.
Spending/Investment, Layoffs
Earnings
Pacific Biosciences has reported revenue of $39 million for Q2, with consumable revenue of $20 million, instrument revenue of $13 million, and service revenue of $6 million. Service revenue declined slightly year-over-year due to the completion of a large population genomics study in Asia.
Earnings, Accounting, Financial Reporting, Finance
Project
Pacific Biosciences has announced that its next high-throughput instrument is designed to achieve better price parity with short-read sequencing, support higher volumes for AI training data set construction, enable potential diagnostic applications, and include tools and variant callers built to integrate seamlessly with AI models.
Product Development, Artificial Intelligence
Earnings
Pacific Biosciences News & Media
Genetic LifeSpan Launches MyHeartCode™ with Dr. Ernst von Schwarz at Beverly Hills Premiere
New cardiovascular assessment gives people with heart concerns or family history a deeper view of how their cardiovascular system may be aging. BEVERLY HILLS, CA, UNITED STATES, August 18, 2026 /EINPresswire.com/ -- Genetic LifeSpan announced the …PacBio Appoints Mark Van Oene as President and Chief Executive Officer
Christian Henry to Transition from President and Chief Executive Officer Following Six Years of Leadership; Effective August 5, 2026 Christian Henry to Transition from President and Chief Executive Officer Following Six Years of Leadership; Effective August 5, 2026PacBio Announces Second Quarter 2026 Financial Results
MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2026.PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system
Vega SPRQ-Nx chemistry to deliver up to 90 Gb per run at 40% lower cost per gigabase, with single-shift runs and new workflow controls for regulated labs Vega SPRQ-Nx chemistry to deliver up to 90 Gb per run at 40% lower cost per gigabase, with single-shift runs and new workflow controls for regulated labs
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pacific Biosciences
Sign Up For FreeTo access detailed company insights
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. The company's innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectr... Read More
